Related Experiment Video
Updated: Aug 10, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Heterologously expressed SacP23, a novel bacteriocin from Paenibacillus polymyxa #23, is active against methicillin
Châu Minh Khánh1,2, Dong Van Quyen3,4, Thi Thu Hao Van1
1School of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Abstract:
Antimicrobial peptides have the potential to be used in a range of applications, including as an alternative to conventional antibiotics for the treatment of bacterial infections of humans and animals. Therefore, there is interest in identifying novel bacteriocins which have desirable physico-chemical properties or antimicrobial activities. Paenibacillus polymyxa #23, isolated from a marine sponge, has wide spectrum antimicrobial activity against Gram-negative and Gram-positive bacteria. To explore the basis of this antimicrobial activity, the complete genome sequence of the strain was examined. Multiple genes predicted to encode antimicrobial peptides were identified. One gene was predicted to encode a novel sactipeptide bacteriocin, named SacP23. To confirm that SacP23 does have antimicrobial activity and to explore the antimicrobial spectrum of the peptide it was heterologously expressed in Bacillus subtilis. A cluster of eight genes, encoding a full complement of accessory genes as well as the structural gene expressed from the native promoter, was cloned into B. subtilis BS54A. The recombinant strain displayed antimicrobial activity against several Gram-positive bacteria, including multi-drug resistant Staphylococcus aureus. Heterologous expression of a whole gene cluster offers a powerful way to interrogate and resolve the various antimicrobial activities expressed by native strains that encode multiple compounds of interest.
Insights
Researchers discovered a novel antimicrobial peptide, SacP23, from *Paenibacillus polymyxa*. This peptide shows broad-spectrum activity, offering a potential alternative to conventional antibiotics against resistant bacteria.
Area of Science:
- Microbiology
- Biochemistry
- Genomics
Background:
- Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics.
- Novel bacteriocins with unique properties are sought for treating bacterial infections.
- The marine sponge-associated bacterium *Paenibacillus polymyxa* #23 exhibits broad-spectrum antimicrobial activity.
Purpose of the Study:
- To identify and characterize novel antimicrobial peptides from *Paenibacillus polymyxa* #23.
- To investigate the genetic basis of the antimicrobial activity of *P. polymyxa* #23.
- To confirm the antimicrobial activity of a novel sactipeptide bacteriocin, SacP23.
Main Methods:
- Whole-genome sequencing of *Paenibacillus polymyxa* #23.
- Bioinformatic analysis to predict genes encoding antimicrobial peptides.
- Heterologous expression of the SacP23 gene cluster in *Bacillus subtilis*.
Main Results:
- Identification of multiple genes encoding antimicrobial peptides, including a novel sactipeptide bacteriocin named SacP23.
- The recombinant *Bacillus subtilis* strain expressing the SacP23 gene cluster demonstrated antimicrobial activity.
- Activity was observed against Gram-positive bacteria, including multi-drug resistant *Staphylococcus aureus*.
Conclusions:
- SacP23 is a novel bacteriocin with confirmed antimicrobial activity.
- Heterologous expression of entire gene clusters is an effective method for studying antimicrobial compounds.
- This approach facilitates the discovery of new antimicrobial agents for therapeutic applications.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

